Acyclovir Oral Suspension Recalled for Manufacturing Practice Deviations
Akorn's Acyclovir Oral Suspension is being recalled nationwide due to manufacturing practice deviations. The firm closed and could not complete required stability studies for the medication.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This recall is classified as FDA Class II, but involves no reported illnesses or injuries. The hazard is precautionary—the firm closed and could not complete required stability studies—rather than a confirmed product defect or contamination. The recall fits the rubric criterion for voluntary precautionary recalls at the Moderate severity level.
Plain-English summary
Akorn, Inc. is recalling all lots of Acyclovir Oral Suspension, 200mg/5mL (prescription only). The medication was distributed nationwide in the United States and Puerto Rico by Akorn Operating Company LLC.
The recall was issued due to Current Good Manufacturing Practice (CGMP) deviations. Akorn ceased operations and could no longer conduct the stability studies required to ensure the product's safety and effectiveness over time.
Patients currently taking this medication should contact their prescribing healthcare provider or pharmacist to discuss the recall and available alternatives.
The recalled product
- Product
- Acyclovir Oral Suspension, 200mg/5mL, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs
- Manufacturer
- Akorn, Inc.
- Category
- Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Part of a larger recall action
This product is one of 86 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 86 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · unverified stability
See all →- HighPrescription eye solution recalled due to discontinued stability studies
FDA (Drugs) · 2023-06-07
- HighLorazepam Injection Recalled Due to Manufacturing Control Deviations
FDA (Drugs) · 2023-06-07
- HighAcetaminophen & Codeine Oral Solution Recalled Due to Unverified Stability
FDA (Drugs) · 2023-06-07
- HighLactulose Solution Recall Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-06-07
- ModerateAzelastine Hydrochloride Nasal Spray Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2023-06-07